Analysis reveals that regional trading agreements may help counteract U.S. tariff chaos and support global trade stability.
executive summary: This essay argues that Asia’s system of regional trading agreements will not protect countries from the uncertain and chaotic U.S. tariff policy but that this system nonetheless might help underpin a global response. main argumentAsian countries are signatories to many trade agreements that have featured innovation, steady persistent cooperation, and large coalitions, all of which are factors that may be important in preserving the world trading system from the Trump administration’s tariffs. However, these agreements are not a unified system and are mostly shallow; thus, without extension they will not produce new trade flows to counter losses in U.S. markets. Although President Donald Trump’s trade policy is chaotic and destructive, his new trade restrictions are unlikely to disappear completely, even with international pressure and hostile equity and bond markets. No Asian country will be able to avoid economic stresses resulting from the reduction in world growth that these policies could cause. The most vulnerable will be the developing countries that have actively pursued export-led development with the U.S. as a primary partner. With uncertainty prevalent, a global response to Trump’s tariffs based on World Trade Organization (WTO) rules is desirable. policy implications• Although it may be a difficult and time-consuming process, Asian countries should extend and deepen their regional trading arrangements. • In negotiating new tariffs with the Trump administration, governments should try to make their responses nondiscriminatory. • At a minimum, countries should not agree explicitly to penalize other countries—for example, by joining Trump’s trade war with China. Governments should deal with China according to their own national interests. • Countries should open negotiations with non-U.S. members of the WTO to liberalize mutual trade and update the WTO’s rules. The U.S. should be allowed to join these talks but not to veto them.
No takes yet. Share an insight, caveat, or question.
Lynn Winters (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: